Your Source for BioScience Venture Capital Data
  • SEARCH THE OnBioVC DATABASE:

  • OnBioVC NEWS:

    - OnBioVC 4Q11 Trend Analysis, now available
    - OnBioVC 1Q12 White Paper, now available
    - OnBioVC 1Q12 Trend Analysis, coming soon

  • Photobucket

  • FDA Registered Contract Manufacturer

OptiMedica (Sunnyvale, CA), a commercial-stage medical device company focused on laser technology for cataract surgery, closed a $35M Series E financing. Participants include Kleiner Perkins Caufield & Byers, Alloy Ventures, DAG Ventures, BlackRock Private Equity Partners and Bio*One Capital.

iRhythm Technologies (San Francisco, CA), a commercial-stage medical device company that focused on cardiac rhythm monitoring, closed a $1.5M Series C financing. Participants include the California HealthCare Foundation.

Edison Pharmaceuticals (Mountain View, CA), a clinical-stage pharmaceutical company developing small molecules to treat mitochondrial disease, closed a $20M Series F financing. Participants include Mitsui & Co. Global Investment.

Cebix (San Diego, CA), a clinical stage biotechnology company developing a modified insulin C-peptide for the treatment of complications associated with diabetes such as peripheral neuropathy, closed a $30.9M Series B financing. Participants were not identified.

Intarcia Therapeutics (Hayward, CA), a clinical stage medical device company focused on developing a subcutaneous device to continuously deliver diabetes therapeutic exenatide, closed a $160M Series C financing, in addition to a $50M debt financing, totaling $210M for the round. Participants include New Enterprise Associates, New Leaf Venture Partners, Venrock, The Baupost Group, and Farallon [...]

CardiAQ Technologies (Irvine, CA), a developmental-stage medical device company focused on percutaneous mitral heart valve replacement, closed a $37.3M Series B financing. Participants include OrbiMed, Versant Ventures, Advent Life Sciences and Broadview Advisors.

TriReme Medical (Pleasanton, CA), a commercial-stage medical device company focused on percutaneous devices for the treatment of coronary and peripheral arterial disease, closed an $18M Series E financing. Participants include Luminor Capital.

MabVax Therapeutics (San Diego, CA), a clinical-stage biotechnology company focused on cancer immunotherapies, closed a $5.3M Series B financing. Participants include Numoda Capital Innovations, Burrill & Co. and RTP Venture Fund. Collective IP | The World’s Largest Technology Transfer Office Marketplace Providing Unrivaled Comprehensive and Accurate Access to Humankinds Most Valuable and Transformative Assets Receive [...]

Epic Sciences (San Diego, CA), a preclinical-stage biotechnology company focused on cancer diagnostics, closed a $13M Series B financing. Participants include Domain Associates, Roche Venture Fund, and Pfizer Venture Investments. Collective IP | The World’s Largest Technology Transfer Office Marketplace Providing Unrivaled Comprehensive and Accurate Access to Humankinds Most Valuable and Transformative Assets Receive Collective [...]

Pearl Therapeutics (Redwood City, CA), a clinical-stage pharmaceutical company focused on the development of therapeutics for respiratory diseases, closed a $65M Series D financing. Participants include Vatera Healthcare Partners, 5AM Ventures, Clarus Ventures and New Leaf Ventures. Collective IP | The World’s Largest Technology Transfer Office Marketplace Providing Unrivaled Comprehensive and Accurate Access to Humankinds Most [...]

Auspex Pharmaceuticals (La Jolla, CA), a clinical-stage pharmaceutical company focused on hyperkinetic movement disorders including Huntington’s disease, Tourette syndrome and tardive dyskinesia, closed a $25M Series D financing. Participants include Panorama Capital, Thomas, McNerney & Partners, CMEA Capital and Sloan Biotech Fund. Collective IP | The World’s Largest Technology Transfer Office Marketplace Providing Unrivaled Comprehensive and [...]

Ambit Biosciences (San Diego, CA), a clinical-stage biotechnology company focused on kinase-based therapeutics for cancer, closed a $25M Series E financing. Participants include OrbiMed Advisors, Aisling Capital, Apposite Healthcare, Roche Ventures, GrowthWorks, MedImmune Ventures, Forward Ventures, GIMV, and Radius Ventures. Collective IP | The World’s Largest Technology Transfer Office Marketplace Providing Unrivaled Comprehensive and Accurate [...]

Advanced Cell Diagnostics (Hayward, CA), a clinical-stage biotechnology company focused on diagnostics and development of therapeutics for Age-related Macular Degeneration and Stargardt’s Macular Dystrophy, closed a $12M Series B financing. Participants include New Leaf Venture Partners and Morningside Ventures. Collective IP | The World’s Largest Technology Transfer Office Marketplace Providing Unrivaled Comprehensive and Accurate Access [...]

« Previous Entries  Next Page »

to top of page...